• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Oral contraceptives and bone mineral density: A population-based study.

作者信息

Pasco J A, Kotowicz M A, Henry M J, Panahi S, Seeman E, Nicholson G C

机构信息

Department of Medicine, St Vincent's and The Geelong Hospitals, the University of Melbourne, Geelong, Victoria, Australia.

出版信息

Am J Obstet Gynecol. 2000 Feb;182(2):265-9. doi: 10.1016/s0002-9378(00)70209-2.

DOI:10.1016/s0002-9378(00)70209-2
PMID:10694322
Abstract

OBJECTIVE

We sought to test the hypothesis that exposure to oral contraceptives protects the skeleton.

STUDY DESIGN

Multiple regression techniques were used to analyze data for a random sample of 710 Australian women (age range, 20-69 years). Bone mineral density was measured at the lumbar spine, proximal femur, whole body, and distal forearm. Oral contraceptive exposure was assessed by a questionnaire.

RESULTS

Women exposed to oral contraceptives had a 3.3% greater mean bone mineral density adjusted for body mass index and age at the lumbar spine (partial r (2) = 0.009; P =.014). Adjusted mean vertebral bone mineral density was 3.3% greater for premenopausal women (partial r (2) = 0.008; P <.05), but the effect did not reach significance among postmenopausal women. Higher bone mineral density was associated with increased duration of exposure, with a mean increase of 3.2% associated with the first 5 years and a further 0.2% with >/=5 years of exposure. No association was detected at other sites.

CONCLUSION

Exposure to oral contraceptives may be associated with higher lumbar spine bone mineral density.

摘要

相似文献

1
Oral contraceptives and bone mineral density: A population-based study.
Am J Obstet Gynecol. 2000 Feb;182(2):265-9. doi: 10.1016/s0002-9378(00)70209-2.
2
Decreased bone turnover in oral contraceptive users.
Bone. 1995 May;16(5):499-503. doi: 10.1016/8756-3282(95)00075-o.
3
Lack of relationship between hip and spine bone mineral density and oral contraceptive use.髋部和脊柱骨密度与口服避孕药使用之间不存在关联。
Eur J Clin Invest. 1993 Feb;23(2):108-11. doi: 10.1111/j.1365-2362.1993.tb00749.x.
4
Bone density in women receiving depot medroxyprogesterone acetate for contraception.接受醋酸甲羟孕酮长效避孕针的女性的骨密度
BMJ. 1991 Jul 6;303(6793):13-6. doi: 10.1136/bmj.303.6793.13.
5
Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study.绝经前女性口服避孕药的使用与骨密度:来自加拿大多中心骨质疏松症研究的基于人群的横断面数据。
CMAJ. 2001 Oct 16;165(8):1023-9.
6
Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity.
Contraception. 1997 Feb;55(2):87-90. doi: 10.1016/s0010-7824(96)00277-6.
7
The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women.口服避孕药对绝经前后女性椎骨骨量的影响。
Contraception. 1986 Oct;34(4):333-40. doi: 10.1016/0010-7824(86)90086-7.
8
Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise.神经性厌食症中的骨质疏松症:峰值骨密度、骨质流失、口服避孕药使用及运动的影响
J Bone Miner Res. 1992 Dec;7(12):1467-74. doi: 10.1002/jbmr.5650071215.
9
Development and reproducibility of the bone loading history questionnaire.骨负荷史问卷的开发与可重复性
Med Sci Sports Exerc. 2006 Jun;38(6):1121-31. doi: 10.1249/01.mss.0000222841.96885.a8.
10
Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months.口服避孕药、甲羟孕酮或安慰剂治疗12个月的下丘脑性闭经年轻女性的骨矿物质变化
Am J Obstet Gynecol. 1997 May;176(5):1017-25. doi: 10.1016/s0002-9378(97)70396-x.

引用本文的文献

1
Hormonal and non-hormonal oral contraceptives given long-term to pubertal rats differently affect bone mass, quality and metabolism.长期给予青春期大鼠的激素和非激素口服避孕药会对骨量、质量和代谢产生不同的影响。
Front Endocrinol (Lausanne). 2023 Aug 17;14:1233613. doi: 10.3389/fendo.2023.1233613. eCollection 2023.
2
Association of Female Reproductive Factors With Incidence of Fracture Among Postmenopausal Women in Korea.韩国绝经后女性骨折发病率与女性生殖因素的相关性研究。
JAMA Netw Open. 2021 Jan 4;4(1):e2030405. doi: 10.1001/jamanetworkopen.2020.30405.
3
Are the Effects of Oral and Vaginal Contraceptives on Bone Formation in Young Women Mediated via the Growth Hormone-IGF-I Axis?
口服和阴道避孕药对年轻女性骨形成的影响是否通过生长激素-IGF-I 轴介导?
Front Endocrinol (Lausanne). 2020 Jun 16;11:334. doi: 10.3389/fendo.2020.00334. eCollection 2020.
4
The effect of oral contraceptive different patterns of use on circulating IGF-1 and bone mineral density in healthy premenopausal women.口服避孕药不同使用模式对健康绝经前女性循环胰岛素样生长因子-1(IGF-1)及骨密度的影响
Endocrine. 2015 Feb;48(1):272-8. doi: 10.1007/s12020-014-0290-2. Epub 2014 May 27.
5
Oral contraceptive use and bone mass in women aged 26-36 years.口服避孕药的使用与 26-36 岁女性的骨量
Osteoporos Int. 2011 Jan;22(1):351-5. doi: 10.1007/s00198-010-1180-y. Epub 2010 Feb 27.
6
The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women.口服避孕药的使用对绝经前后健康女性的骨密度、骨生化标志物和肌肉力量的影响。
BMC Womens Health. 2009 Nov 3;9:31. doi: 10.1186/1472-6874-9-31.
7
Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review.口服避孕药和激素替代疗法对绝经前和围绝经期女性骨密度的影响:一项系统评价
Br J Sports Med. 2006 Jan;40(1):11-24. doi: 10.1136/bjsm.2005.020065.
8
Oral contraceptive use in young women is associated with lower bone mineral density than that of controls.年轻女性使用口服避孕药与骨矿物质密度低于对照组有关。
Osteoporos Int. 2005 Dec;16(12):1538-44. doi: 10.1007/s00198-005-1868-6. Epub 2005 May 19.
9
Premenopausal bone health assessment.绝经前骨健康评估。
Curr Rheumatol Rep. 2005 Mar;7(1):46-52. doi: 10.1007/s11926-005-0008-9.
10
Noncontraceptive health benefits of oral contraceptives.口服避孕药的非避孕健康益处。
Rev Endocr Metab Disord. 2002 Sep;3(3):277-83. doi: 10.1023/a:1020084728544.